Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroartemisinin in PCOS
NCT05465135Phase 4Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jul 2022
- Primary completion
- Mar 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dihydroartemisinin in polycystic ovary syndrome (PCOS), sponsored by Zhongshan Hospital, Fudan University. Started Jul 2022; status: completed.
02
Drugs
dihydroartemisinin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05465135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05465135.